Navigation Links
Human Primary Preadipocytes and Differentiated Adipocytes


Human Primary Preadipocytes and Differentiated Adipocytes

A new paradigm for energy metabolism research

Yuan-Di C. Halvorsen
Zen-Bio, Inc.

Peter Pingerelli Matt C. Petre
Stratagene

Regis Saladin
Ligand Pharmaceuticals

Michael R. Briggs
SmithKline Beecham Pharmaceuticals

Stratagene introduces new tools to facilitate the study of human adipocyte biology: Human Predifferentiated Adipocytes and Human Differentiated Adipocytes. Adipose tissue is a differentiated endocrine organ that primarily functions to manage energy homeostasis. Human primary adipocytes represent a model system to study these complex processes. The stromal-vascular fraction from adipose tissue can be processed to isolate preadipocytes and induced with hormones to differentiate into adipocytes. The resulting in vitro differentiated cells are functionally similar to primary human adipocytes and can be cultured for weeks without loss of adipocyte-specific markers, unlike the fragile primary adipocytes that die within 24 hours.

The study of adipocyte biology is important not only to understand metabolic diseases (including obesity, diabetes, dyslipidemia, and atherosclerosis), but to develop pharmacological agents to treat such maladies. Adipose tissue is critical for maintaining energy balance, because it serves both as a storage depot and an endocrine organ.1 It is actively involved in sensing the nutritional state of the organism through several different signaling pathways. It responds by altering the expression of genetic pathways to mobilize or store energy and activating signals to other tissues to regulate energy balance.

Previously, all research in adipocyte biology was conducted using rodent cells, mainly transformed cell lines.2 However, because humans and rodents have distinct genetic backgrounds and metabolic pathways, potential experimental pitfalls were inevitable. For example, compounds effective in activating the b3-adrenergic pathway in rodents failed to stimulate human adipocytes to burn more fat.3 Stratagene now offers Human Predifferentiated Adipocytes and Human Differentiated Adipocytes, so rodent systems can be bypassed for human systems in experiments involving adipocyte signal transduction pathways or gene regulation.

Human Preadipocyte Differentiation

When excess preadipocytes are recruited into the differentiated adipocyte, obesity results. Since from adolescence through adulthood humans continue to recruit cells to become adipocytes, it is of interest to study the environmental and humoral factors that initiate and maintain the differentiated phenotype of adipocytes. Human preadipocytes provide the tools to explore the most relevant factors that influence human obesity.

Stratagene recently developed the Adipocyte Differentiation Kit, which uses a simple and efficient method to differentiate human primary preadipocytes into mature, fully functional adipocytes. Undifferentiated preadipocytes are cultured in DMEM/F-10 (1:1, v/v) with 10% fetal bovine serum. The cells can be passaged for expansion, frozen for later reuse, or differentiated. The absence of staining with antisera to factor VIII and lack of vascular endothelial growth factor receptor mRNA, shown by Northern analysis, 4 demonstrated that no endothelial cells are present in the preadipocyte culture.

Earlier passage cells are more robust in both growth and differentiation potential; passages one to three are ideal. Stratagene uses only passage-two human preadipocytes for the Adipocyte Differentiation Kit. Typically, a production lot of cells is isogenic, and lots vary within the 10% to 20% range for total differentiation potential, as measured by lipid accumulation.

Up to 90% of the Human Predifferentiated Adipocytes can be induced to differentiate after they have been treated with a hormone and chemical cocktail. This treatment promotes a cascade of transcription factors activation and adipocyte-specific gene expression that leads to the mature adipocyte phenotype (Figure 1, panel A and B). Predifferentiated Adipocyte Differentiation Medium is also available from Stratagene as a separate reagent.

Figure 1

During the differentiation process5, key adipocyte- specific genes, such as PPARg, fatty acid binding protein, and obese gene, are expressed.6,7,8 Expression of signaling molecules, such as leptin, the obese gene product is induced during differentiation (Figure 2).

Figure 2

Practical Applications

By using Stratagenes Human Predifferentiated Adipocytes, various questions can be addressed: What makes these cells differentiate from fibroblast-like cells to adipocytes? What are adipocytes similarities and differences? What chemical and endocrine effectors transform preadipocytes? What gene expression changes are necessary and/or sufficient for preadipocyte transformation?

Human Predifferentiated Adipocytes are available in a 24- or 96-well format and are shipped ready to use. Besides providing a unique tool to study the processes that trigger and promote differentiation, these cells can be used to identify agents that block or slow the differentiation process.

Human Adipocyte-Specific Gene Expression

By characterizing gene expression and regulation, we may unravel the mysteries of the adipocytefrom its role as an endocrine receptor to its role as a mediator of energy homeostasis. Transfection experiments, which lead to overexpression of wild type or mutated protein forms, are used to characterize many gene functions. The phenotype of the altered expression state allows the effects of single gene changes to be examined, which may model metabolic derangement associated with particular diseases.9

To date we have successfully transfected Human Differentiated Adipocytes with the human adipose- specific obese gene and peroxisome proliferator activated receptor gamma (PPARg) gene promoter-driven reporters (data not shown). In experiments to improve the transfectability of Human Differentiated Adipocytes or Human Predifferentiated Adipocytes using Stratagenes Transfection MBS Mammalian Transfection Kit or LipoTAXI Transfection Reagent, respectively, we showed that including the Primary Transfection ENHANCER results in a higher transfection efficiency (Figure 3, panel A and panel B).

Figure 3

Lipolysis: A Differentiated Adipocyte Process

One of the key functions of adipocytes is to adjust lipid storage according to the physiological energy needs of the organism. When extra calories are required, adipocyte intracellular triglyceride stores are metabolized to glycerol and fatty acids for further oxidation, a process termed lipolysis.10 Our Human Differentiated Adipocytes respond to adrenergic hormone receptor agonists, such as norepinephrine or isoproterenol, to induce this metabolic pathway. The lipolysis response can be assayed by measuring the release of glycerol into the culture medium (Figure 4). Thus, these cells are useful for analyzing compounds or genes that induce, or are involved with, this important function of the mature adipocyte.

Figure 4

Conclusions

With Stratagenes new Human Predifferentiated Adipocytes and Human Differentiated Adipocytes, researchers have a new class of reagents with which to study human adipose biology. It is now possible to directly study the factors that affect human adipose differentiation, and to identify agents which may promote or interfere with the progression of obesity. Gene expression in both adipocytes and preadipocytes can be achieved with the aid of Primary Transfection ENHANCER, a new reagent developed by Stratagene to enhance primary cell transfection.

REFERENCES
  1. Flier, J. (1995) Cell 80: 15-18.

  2. Green, H. and Kehinde, O. (1975) Cell 5: 19-27.

  3. Arch, J.R.S. and Wilson, S. (1996) Int. J. Obes. 20: 191-199.

  4. Claffey, K. and Halvorsen, Y.C. unpublished results.

  5. Halvorsen, Y. C. unpublished results.

  6. Lehmann, J.M., et al. (1995) J. Clin. Invest. 270: 12953-12956.

  7. Tontonoz, P. Hu, E. and Spiegelman, B.M. (1994) Cell 79: 1147-1156.

  8. Brun, R.P., et al. (1996) Genes and Develop. 10: 974-984.

  9. Fraser, J.D., et al. (1997) J. Biol. Chem. 272: 13892-13898.

  10. Chernick, S., et al. (1986) J. of Lipid Res. 27: 286-294.


'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
2. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
3. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
4. Human Universal cDNA Library Array I
5. Map and Link Human Genetic Disorders with SSLP Analysis
6. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
7. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
8. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
9. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
10. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
11. Stratagenes Human cDNA Microarrays: Perform Gene Expression Profiling and Discover New Genes
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Human Primary Preadipocytes and Differentiated Adipocytes

(Date:5/4/2015)... 4, 2015  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... address unmet medical needs in the areas of inflammation, ... presenting preclinical data from three of its biodefense programs ... Technology Conference on May 12-14, 2015 to be held ... Plaza, St. Louis MO 63101. ...
(Date:5/4/2015)... , May 4, 2015   Sentrian ™, the ... has teamed with the Scripps Translational Science Institute ... on 1,000 patients with chronic obstructive pulmonary disease (COPD), ... and is the nation,s third leading cause of death. ... CareMore Health System , a wholly owned subsidiary of ...
(Date:5/1/2015)... May 1, 2015 Pfenex Inc. (NYSE ... the development of biosimilar therapeutics including high value ... its first quarter 2015 financial results will be ... open of market. At 8:30 am Eastern Time, Pfenex ... the financial results and provide a business update. A ...
(Date:5/1/2015)... -- According to a new market ... by Type (Monoclonal, Polyclonal), by Technology (Hybridoma), by ... Analysis & Global Forecast to 2019", published by ... Market for the forecast period of 2014 to ... Billion by 2019 from $1.425 Billion in 2014, ...
Breaking Biology Technology:Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 2Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 3Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 4Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 5Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 6Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 7Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 8Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 9Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 10Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 11Soligenix Announces Presentation and Poster at the 2015 Chemical and Biological Defense Science and Technology Conference in St. Louis, MO 12CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 2CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 3CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 4CareMore, Scripps Translational Science Institute, and Sentrian Launch Landmark Study of Remote Patient Monitoring for COPD Population 5Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Antibody Production Market worth $2.572 Billion by 2019 2Antibody Production Market worth $2.572 Billion by 2019 3Antibody Production Market worth $2.572 Billion by 2019 4
... 13 ,Exelixis, Inc. (Nasdaq: EXEL ) today announced ... common stock. The net proceeds of the,offering are approximately ... shares in the offering are being sold by,Exelixis. Exelixis ... up to an additional 1,050,000 shares of common stock. ...
... PITTSBURGH, Sept. 13 The Pittsburgh Life ... region,s life,sciences industry on a fast track ... and Chief Executive Officer, Renal Solutions, Inc., ... Initiatives, UPMC, John,L. Miclot, President and Chief ...
... September 13 In order,to meet its obligations under ... ("Shire") (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) is,publishing today ... June 2007,in accordance with International Financial Reporting Standards (IFRS). ... 2007, Shire announced its results in,respect of the same ...
Cached Biology Technology:The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors 2The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors 3IFRS Information - First Half of 2007 2IFRS Information - First Half of 2007 3IFRS Information - First Half of 2007 4IFRS Information - First Half of 2007 5IFRS Information - First Half of 2007 6IFRS Information - First Half of 2007 7IFRS Information - First Half of 2007 8IFRS Information - First Half of 2007 9IFRS Information - First Half of 2007 10IFRS Information - First Half of 2007 11IFRS Information - First Half of 2007 12IFRS Information - First Half of 2007 13IFRS Information - First Half of 2007 14IFRS Information - First Half of 2007 15IFRS Information - First Half of 2007 16IFRS Information - First Half of 2007 17IFRS Information - First Half of 2007 18IFRS Information - First Half of 2007 19IFRS Information - First Half of 2007 20IFRS Information - First Half of 2007 21IFRS Information - First Half of 2007 22IFRS Information - First Half of 2007 23IFRS Information - First Half of 2007 24IFRS Information - First Half of 2007 25IFRS Information - First Half of 2007 26IFRS Information - First Half of 2007 27IFRS Information - First Half of 2007 28IFRS Information - First Half of 2007 29IFRS Information - First Half of 2007 30IFRS Information - First Half of 2007 31IFRS Information - First Half of 2007 32IFRS Information - First Half of 2007 33
(Date:4/8/2015)...  Infinisource, a leading provider of SaaS-based Human Capital ... leading supplier of biometric identification and security solutions, ... advanced biometrically-enabled time clock, the companies announced today. ... setting a bold, new standard for the collection ... and mid-size employer. When connected to the iSolved ...
(Date:4/2/2015)... -- Fingerprint Cards (FPC) has received an ... distributor World Peace Industrial Group (WPI), part of WPG ... major part of the shipments will take place during ... manufacturers in China . The order ... revenue guidance of + 1 000 MSEK for 2015.  ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... mutated or expressed in high concentrations can cause normal cells ... demonstrating that Ras, one of the first oncogenes discovered, has ... Ph.D. student Oded Rechavi and his fellow researchers at Tel ... the ability to transfer from cancer cells into immune cells ...
... CORVALLIS, Ore. Researchers at Oregon State University recently completed ... toxicology, and the findings challenge some basic concepts about how ... considered safe. The study found that acceptable levels of ... higher than is currently believed. It also indicates that for ...
... University have developed a laboratory robot that can successfully locate ... to its exact location - all without the need for ... to believe that in the future, such a robot could ... might also be used for such medical procedures as placing ...
Cached Biology News:Cancer-causing protein can also help fight the tumors it causes 2Improved method developed to test carcinogen risk 2Improved method developed to test carcinogen risk 3Autonomous robot detects shrapnel 2Autonomous robot detects shrapnel 3
...
Rad 50 Immunogen: c-terminal mRad 50 (604 amino acids). Storage: 4 C...
...
... for 10 separate biopanning experiments, complexity ... gIII Sequencing Primer (100 pmol), for ... Primer (100 pmol), for automated DNA ... Control target (Streptavidin) and Elutant (Biotin), ...
Biology Products: